{
  "trial_id": "NCT00504660",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "histologically proven supratentorial anaplastic oligodendrogliomas, anaplastic mixed oligoastrocytomas anaplastic astrocytomas or glioblastoma multiforme",
      "label": "met"
    },
    {
      "criterion": "unequivocal evidence for tumor recurrence or progression by MRI scan performed within 14 days prior to enrollment or documented recurrence by tumor resection",
      "label": "met"
    },
    {
      "criterion": "received radiation therapy previously",
      "label": "met"
    },
    {
      "criterion": "equal to or greater than 12 years old",
      "label": "met"
    },
    {
      "criterion": "Karnofsky performance status of equal to or greater than 60",
      "label": "met"
    },
    {
      "criterion": "recovered from the toxic effects of prior therapy: 4 weeks from prior cytotoxic therapy and/or at least two weeks from vincristine, 6 weeks from nitrosoureas, 3 weeks from procarbazine administration, and 1 week for non-cytotoxic agents",
      "label": "met"
    },
    {
      "criterion": "adequate bone marrow function (ANC equal or greater than 1,500/mm^3 and platelet count of equal or greater than 100,000/mm^3)",
      "label": "met"
    },
    {
      "criterion": "adequate liver function (SGPT and alkaline phosphatase <2 times normal, bilirubin <1.5 mg%)",
      "label": "met"
    },
    {
      "criterion": "adequate renal function (BUN and creatinine <1.5 times institutional normal)",
      "label": "met"
    },
    {
      "criterion": "all patients must sign an informed consent indicating that they are aware of the investigational nature of this study in keeping with the policies of this hospital",
      "label": "unknown"
    },
    {
      "criterion": "The baseline on-study MRI is performed within 14 days of enrollment and on a steroid dosage that has been stable.",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients with a history of any other cancer (except non-melanoma skin cancer or carcinoma in-situ of the cervix), unless in complete remission and off of all therapy for that disease for a minimum of 3 years",
      "label": "triggers"
    },
    {
      "criterion": "Patients of childbearing potential must not be pregnant or become pregnant.",
      "label": "met"
    },
    {
      "criterion": "Patients must not have: active infection; disease that will obscure toxicity or dangerously alter drug metabolism; serious intercurrent medical illness",
      "label": "unknown"
    }
  ],
  "notes": "Patient has a history of anaplastic astrocytoma of the spine complicated by severe lower extremity weakness and urinary retention s/p Foley catheter, high-dose steroids, hypertension, and chronic pain. The tumor is located in the T-L spine, unresectable anaplastic astrocytoma s/p radiation.",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT00504660",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}